Difference in Biomarker Profiles in Heart Failure With Reduced and Preserved Ejection Fraction

Cardiologia Croatica - Croatia
doi 10.15836/ccar2017.353
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Medical Publishing, d.o.o.

Related search

Prognosis of Heart Failure With Stable Mid-Range Ejection Fraction in Comparison to Heart Failure With Stable Reduced Ejection Fraction and Heart Failure With Stable Preserved Ejection Fraction

Journal of Cardiac Failure
Cardiovascular MedicineCardiology
2019English

Prognosis in Heart Failure With Preserved Ejection Fraction

sudan heart journal
2017English

Biomarkers in Acutely Decompensated Heart Failure With Preserved or Reduced Ejection Fraction

American Heart Journal
Cardiovascular MedicineCardiology
2012English

Prognosis and NT-proBNP in Heart Failure Patients With Preserved Versus Reduced Ejection Fraction

Heart
Cardiovascular MedicineCardiology
2019English

Non-Cardiac Comorbidities in Heart Failure With Reduced, Mid-Range and Preserved Ejection Fraction

International Journal of Cardiology
Cardiovascular MedicineCardiology
2018English

Biomarkers and Prognostication in Heart Failure With Reduced and Preserved Ejection Fraction: Similar but Different?

European Journal of Heart Failure
Cardiovascular MedicineCardiology
2017English

Microvascular Rarefaction and Heart Failure With Preserved Ejection Fraction

Frontiers in Cardiovascular Medicine
Cardiovascular MedicineCardiology
2019English

Spironolactone for Heart Failure With Preserved Ejection Fraction

New England Journal of Medicine
Medicine
2014English

Comparison of Usefulness of SYNTAX Score in Heart Failure Patients With Preserved Ejection Fraction Versus Those With Reduced Ejection Fraction

Journal of Cardiac Failure
Cardiovascular MedicineCardiology
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy